METHODS AND COMPOSITIONS FOR THE MEDIATION OF NSAID-INDUCED REACTIONS
申请人:NuBioPharma, LLC
公开号:US20150297534A1
公开(公告)日:2015-10-22
Administration of an NSAID with at least one dual inhibitor of mPGES-1 and NF-κB plus at least one zwitterionic phospholipid rests in a lessening of side effects and the ability to administer smaller doses of an NSAID without loss of effectiveness.